Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes

被引:66
作者
Bernardi, Stella [1 ,2 ,3 ]
Fabris, Bruno [4 ]
Thomas, Merlin [3 ]
Toffoli, Barbara [5 ]
Tikellis, Christos [3 ]
Candido, Riccardo [6 ]
Catena, Cristiana [8 ]
Mulatero, Paolo [9 ]
Barbone, Fabio [7 ]
Radillo, Oriano [5 ]
Zauli, Giorgio [5 ]
Secchiero, Paola [1 ,2 ]
机构
[1] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy
[2] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy
[3] Heart & Diabet Res Inst, Baker IDI, Melbourne, Vic 3004, Australia
[4] Univ Trieste, Osped Cattinara, Dept Med Surg & Hlth Sci, I-34149 Trieste, Italy
[5] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34100 Trieste, Italy
[6] Diabetol Ctr, I-34148 Trieste, Italy
[7] Univ Udine, Osped Santa Maria della Misericordia, Dept Med Expt & Clin Sci, I-33100 Udine, Italy
[8] Univ Udine, Osped Santa Maria della Misericordia, Dept Med & Biol Sci, I-33100 Udine, Italy
[9] Univ Turin, Osped San Giovanni Battista, Div Internal Med & Hypertens, I-10126 Turin, Italy
关键词
Metabolic syndrome; High-fat diet; Adipose tissue; Osteoprotegerin; Inflammation; FULL-LENGTH OSTEOPROTEGERIN; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; KAPPA-B LIGAND; INSULIN-RESISTANCE; RECEPTOR ACTIVATOR; DIABETES-MELLITUS; CIRCULATING OSTEOPROTEGERIN; OBESE WOMEN; WEIGHT-LOSS;
D O I
10.1016/j.mce.2014.06.004
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Background: Inflammation is believed to link obesity to insulin resistance, as in the setting of metabolic syndrome (MetS). Osteoprotegerin (OPG) is a soluble protein that seems to exert proatherogenic and prodiabetogenic effects. This study aims at determining OPG levels in MetS and whether OPG might contribute to MetS development and progression. Methodology/principal findings: Circulating OPG was measured in 46 patients with MetS and 63 controls, and was found significantly elevated in those with MetS. In addition, circulating and tissue OPG was significantly increased in high-fat diet (HFD) fed C57BL6 mice, which is one of the animal models for the study of MetS. To evaluate the consequences of OPG elevation, we delivered this protein to C57BL6 mice, finding that it promoted systemic and adipose tissue proinflammatory changes in association with metabolic abnormalities. Conclusions/significance: These data suggest that OPG may trigger adipose tissue proinflammatory changes in MetS/HFD-induced obesity. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 55 条
[1]
Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome [J].
Akinci, Baris ;
Celtik, Aygul ;
Yuksel, Faize ;
Genc, Sinan ;
Yener, Serkan ;
Secil, Mustafa ;
Ozcan, Mehmet Ali ;
Yesil, Sena .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 91 (01) :26-31
[2]
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[3]
Expression and regulation of osteoprotegefin in adipose tissue [J].
An, Juan-Ji ;
Han, Dong-He ;
Kim, Dol-Mi ;
Kim, Se-Hwa ;
Rhee, Yurnie ;
Lee, Eun-Jig ;
Lim, Sung-Kil .
YONSEI MEDICAL JOURNAL, 2007, 48 (05) :765-772
[4]
Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects [J].
Ashley, David T. ;
O'Sullivan, Eoin P. ;
Davenport, Colin ;
Devlin, Niamh ;
Crowley, Rachel K. ;
McCaffrey, Noel ;
Moyna, Niall M. ;
Smith, Diarmuid ;
O'Gorman, Donal J. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (07) :994-1000
[5]
Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients [J].
Augoulea, Areti ;
Vrachnis, Nikolaos ;
Lambrinoudaki, Irene ;
Dafopoulos, Konstantinos ;
Iliodromiti, Zoe ;
Daniilidis, Angelos ;
Varras, Michail ;
Alexandrou, Andreas ;
Deligeoroglou, Efthymios ;
Creatsas, George .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
[6]
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[7]
TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases [J].
Bernardi, Stella ;
Milani, Daniela ;
Fabris, Bruno ;
Secchiero, Paola ;
Zauli, Giorgio .
CURRENT DRUG TARGETS, 2012, 13 (09) :1215-1221
[8]
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation [J].
Bernardi, Stella ;
Zauli, Giorgio ;
Tikellis, Christos ;
Candido, Riccardo ;
Fabris, Bruno ;
Secchiero, Paola ;
Cooper, Mark E. ;
Thomas, Merlin C. .
CLINICAL SCIENCE, 2012, 123 (9-10) :547-555
[9]
Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[10]
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women [J].
Browner, WS ;
Lui, LY ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :631-637